
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Amarin(SIGNIFICANT), Esperion(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Novo Nordisk Inc.(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Amarin(SIGNIFICANT), Novartis Corporation(SIGNIFICANT)
CONSULTING FEES/HONORARIA: Amarin(SIGNIFICANT), Esperion(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Novo Nordisk Inc.(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Amarin(SIGNIFICANT), Novartis Corporation(SIGNIFICANT)
© 2021 American College of Cardiology Foundation. All rights reserved.